Ukraine Advances With Drone-Infantry Warfare Model, Reclaims Territory in the South 
Russia Unleashes Massive Drone and Missile Barrage on Ukraine, Killing Civilians 
Hungary's Orban Loses Power: What It Means for Europe's Far Right 
Brazil's Former Intelligence Chief Alexandre Ramagem Released from U.S. Immigration Custody 
Iran Offers Partial Strait of Hormuz Access Amid U.S. Peace Talks 
Federal Judge Dismisses DOJ Lawsuit Attempting to Block Hawaii's Climate Case Against Oil Giants 
Erica Schwartz Reportedly Tapped to Lead the CDC Under Trump Administration 
Trump Warns Against Iranian Nuclear Weapons, Criticizes Pope Leo 
DHS Shutdown Delays World Cup Security Planning Despite Full Funding Release 
Justice Jackson Slams Supreme Court's Growing Use of Shadow Docket 
Pentagon Taps Auto Giants to Supercharge U.S. Weapons Production 
U.S. Blockade on Iran Tightens Amid Ceasefire Uncertainty 
Federal Agencies Secretly Test Anthropic's AI Despite Trump Administration Ban 
Japan Opens Arms Export Floodgates: New Policy Draws Global Defense Interest 
Russia's Uranium Proposal for Iran Rejected by the U.S., Kremlin Confirms 
Prince Harry Opens Up About Fatherhood and Mental Health During Australia Visit 
Israel-Hezbollah War: Netanyahu Vows to Dismantle Militia and Secure Peace Through Strength 
The White House is reportedly considering former Deputy Surgeon General Erica Schwartz as its next nominee to lead the Centers for Disease Control and Prevention, according to a source familiar with ongoing internal discussions. Schwartz, who held senior public health responsibilities during President Donald Trump's first term, played a central role in managing the federal government's COVID-19 response, with oversight spanning national preparedness and interagency coordination.
Her potential nomination comes amid a period of significant leadership instability at the CDC. Former Director Susan Monarez was dismissed last August after publicly opposing vaccine policy changes championed by Health and Human Services Secretary Robert F. Kennedy Jr. Following Monarez's departure, HHS Deputy Secretary Jim O'Neill stepped in as acting CDC director before Jay Bhattacharya — currently heading the National Institutes of Health — assumed the role in February. O'Neill has since transitioned to lead the National Science Foundation.
Schwartz's prospective appointment has drawn early praise from notable public health figures across the political spectrum. Brett Giroir, who served as assistant secretary of health under the first Trump administration, highlighted her strong character and commitment to public service. Demetre Daskalakis, a former senior CDC immunization official who stepped down last year over vaccine policy disputes, credited Schwartz with demonstrating effective leadership throughout the pandemic and praised her work strengthening preparedness within the commissioned corps.
Washington Post reporter Dan Diamond also noted that Texas health commissioner Jen Shuford and senior FDA official Sara Brenner are being considered for other high-level CDC positions. Daskalakis suggested the three could form a capable leadership team, provided they are given the autonomy to operate independently of political interference from the HHS secretary.
No formal announcement regarding Schwartz's nomination has been made at this time.
